Sunvozertinib for NSCLC with EGFR Exon 20 - Lung Cancer OncInsights 2025-26 скачать в хорошем качестве

Sunvozertinib for NSCLC with EGFR Exon 20 - Lung Cancer OncInsights 2025-26

In this video series that was recorded in July, September and November of 2025, leading oncologists present patients and caregivers with the most current and emerging treatment information in lung cancer, delivered in a concise and easy-to-understand format. In this video, Dr. Raez discusses sunvozertinib, a drug recently approved in July 2025 to treat advanced non-small cell lung cancer (NSCLC) with an EGFR Exon 20 insertion mutation. View transcripts here: https://drive.google.com/file/d/1bCoL... Thank you to our Sponsors! #janssen #genentech #lilly and Summit Therapeutics Music: Ester - Here (BenSound) License: 2242649 For more, please visit https://cancerGRACE.org/. To join the conversation or ask a question, visit https://cancergrace.org/forum. To follow along with this video using the YouTube transcript, click Show Transcript at the bottom of the YouTube description. To translate that transcript into other languages while using chrome, right click and click on translate, click the three dots, and click 'Choose another language'. Find your chosen language in the dropdown list.